sprout health tirzepatide Tirzepatide-Weightloss Semaglutide & Tirzepatide Weight Loss

Controlled Substances Act as of 2026-04

Quave is wary of the easy availability of single-ingredient supplements like berberine, which are sold in powerful compound form with few warnings about potential side effects, and without the same regulatory scrutiny as over-the-counter or prescription medications

Key Highlights (72 weeks study): Resolution of steatohepatitis: 62.9% (semaglutide) vs 31.5% (placebo) Fibrosis improvement (1 stage): 36.8% vs 22.4% Average weight reduction: ~10% Better metabolic and liver markers Safety: Mostly mildmoderate GI side effects While semaglutide is not yet an approved antifibrotic, this data represents a major advancement in addressing both metabolic and hepatic components of the disease

Preserved Acetylcysteine A powerful antioxidant precursor that boosts glutathione production

This pH-stable formula is designed to remain active in both acidic and alkaline gastrointestinal conditions, enabling it to effectively digest fats